ProShare Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.8K | Sell |
|
|||||
|
2025
Q1 | $21.2K | Sell |
|
|||||
|
2024
Q4 | $55.5K | Buy |
|
|||||
|
2024
Q3 | $66.2K | Buy |
|
|||||
|
2024
Q2 | $37.2K | Sell |
|
|||||
|
2024
Q1 | $112K | Buy |
|
|||||
|
2023
Q4 | $52.5K | Sell |
|
|||||
|
2023
Q3 | $37K | Buy |
|
|||||
|
2023
Q2 | $82.8K | Buy |
|
|||||
|
2023
Q1 | $94.6K | Sell |
|
|||||
|
2022
Q4 | $202K | Buy |
|
|||||
|
2022
Q3 | $418K | Buy |
|
|||||
|
2022
Q2 | $450K | Sell |
|
|||||
|
2022
Q1 | $1.05M | Sell |
|
|||||
|
2021
Q4 | $1.94M | Buy |
|
|||||
|
2021
Q3 | $1.94M | Sell |
|
|||||
|
2021
Q2 | $3.27M | Buy |
|
|||||
|
2021
Q1 | $2.75M | Buy |
|
|||||
|
2020
Q4 | $2.67M | Buy |
|
|||||
|
2020
Q3 | $910K | Buy |
|
|||||
|
2020
Q2 | $718K | Buy |
|
|||||
|
2020
Q1 | $310K | Sell |
|
|||||
|
2019
Q4 | $481K | Buy |
|
|||||
|
2019
Q3 | $367K | Sell |
|
|||||
|
2019
Q2 | $517K | Sell |
|
|||||
|
2019
Q1 | $501K | Buy |
|
|||||
|
2018
Q4 | $363K | Buy |
|